Patents by Inventor Garrett Marin
Garrett Marin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12138425Abstract: Disclosed herein are apparatuses and methods that account for exercise in closed loop insulin delivery systems. Rather than increasing a target insulin on board (IOB) as glucose levels rise, which would increase insulin delivery to address the raised glucose levels, when a user indicates that the user will be exercising raised glucose levels are addressed by reducing the target IOB within the closed loop algorithm. By reducing the target IOB, the algorithm responds less aggressively to pre-exercise food, and does not build up the IOB that can cause dangerously low glucose levels once the exercise also begins lowering glucose levels.Type: GrantFiled: May 20, 2020Date of Patent: November 12, 2024Assignee: Tandem Diabetes Care, Inc.Inventors: Thomas R. Ulrich, Michael Michaud, Geoffrey A. Kruse, Paul Harris, Garrett Marin
-
Publication number: 20240350728Abstract: Disclosed herein are systems and methods for mitigating the risk of insulin stacking in automated insulin delivery systems. In AID systems configured to both automatically calculate insulin delivery based on glucose levels and receive manual programming of meal boluses configured to counteract carbohydrates in a meal, insulin stacking can result if the system automatically increases insulin delivery based on a rise in glucose levels in response to consumption of a meal and the user later programs a meal bolus for the meal. The risk of such double dosing is mitigated by the systems and methods disclosed herein by enabling the system to account for recent automated insulin increases when a meal bolus is programmed.Type: ApplicationFiled: April 18, 2023Publication date: October 24, 2024Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Scott Leas, Betsy Dokken, Garrett Marin, Nicholas Sherer
-
Publication number: 20240269383Abstract: Disclosed herein are apparatuses and methods incorporating an infusion pump and a CGM that can include software that automatically populates a blood glucose section of a bolus calculator with a most recent valid CGM value. The software can additionally be programmed to automatically populate the bolus calculator with a single CGM reading only when one or more predefined conditions are met that aid in mitigating the risk of inaccurate and/or invalid singleCGMreadings.Type: ApplicationFiled: April 16, 2024Publication date: August 15, 2024Inventors: Michael MICHAUD, Garrett MARIN, Geoffrey A. KRUSE, Jacob KEARNS, Thomas R. ULRICH, Trevor DENBO, David BERGER
-
Publication number: 20240157052Abstract: Apparatuses and methods for transitioning to sleep mode or otherwise modified glucose target range in automated insulin delivery systems. For example, sleep mode can include a lower glucose target and/or lower and narrower glucose target range because of fewer variables that affect glucose values during sleep such as eating and exercise. Due to increased stability provided by the sleep mode target range, it is desirable to transition to the sleep mode target range as quickly as possible, while ensuring the transition is done safely and does not risk low glucose or hypoglycemia by too quickly switching to the lower and narrower target range. Systems and methods disclosed herein therefore provide various approaches for safely and quickly transitioning to sleep mode or other modified target ranges in order to improve time in range by being more aggressive to get to the lower sleep mode or other target faster without risking hypoglycemia.Type: ApplicationFiled: January 22, 2024Publication date: May 16, 2024Inventors: Alexandra Elena Constantin, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Virginia S. Lu, Garrett Marin
-
Patent number: 11969576Abstract: Disclosed herein are apparatuses and methods incorporating an infusion pump and a CGM that can include software that automatically populates a blood glucose section of a bolus calculator with a most recent valid CGM value. The software can additionally be programmed to automatically populate the bolus calculator with a single CGM reading only when one or more predefined conditions are met that aid in mitigating the risk of inaccurate and/or invalid single CGM readings.Type: GrantFiled: July 6, 2020Date of Patent: April 30, 2024Assignee: Tandem Diabetes Care, Inc.Inventors: Michael Michaud, Garrett Marin, Geoffrey A. Kruse, Jacob Kearns, Thomas R. Ulrich, Trevor Denbo, David Berger
-
Publication number: 20240127923Abstract: Disclosed herein are systems and methods for remotely monitoring and/or controlling medical therapy of a patient. Embodiments of the current disclosure provide a remote monitoring and/or control architecture that can establish a predetermined set of permissions for real time monitoring of patient data and/or notifications and/or control of medical device therapy. The system can include permissions to determine who, how and when information and/or control is shared that can consider factors such as time, location and relationship with the patient.Type: ApplicationFiled: December 27, 2023Publication date: April 18, 2024Inventors: Manuel Jaime, Josh Juster, Larkin Lowrey, Geoffrey A. Kruse, Garrett Marin, Michael Michaud
-
Patent number: 11951284Abstract: Apparatuses and methods for transitioning to sleep mode or otherwise modified glucose target range in automated insulin delivery systems. For example, sleep mode can include a lower glucose target and/or lower and narrower glucose target range because of fewer variables that affect glucose values during sleep such as eating and exercise. Due to increased stability provided by the sleep mode target range, it is desirable to transition to the sleep mode target range as quickly as possible, while ensuring the transition is done safely and does not risk low glucose or hypoglycemia by too quickly switching to the lower and narrower target range. Systems and methods disclosed herein therefore provide various approaches for safely and quickly transitioning to sleep mode or other modified target ranges in order to improve time in range by being more aggressive to get to the lower sleep mode or other target faster without risking hypoglycemia.Type: GrantFiled: August 27, 2021Date of Patent: April 9, 2024Assignee: Tandem Diabetes Care, Inc.Inventors: Alexandra Elena Constantin, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Virginia S. Lu, Garrett Marin
-
Patent number: 11869650Abstract: Disclosed herein are systems and methods for remotely monitoring and/or controlling medical therapy of a patient. Embodiments of the current disclosure provide a remote monitoring and/or control architecture that can establish a predetermined set of permissions for real time monitoring of patient data and/or notifications and/or control of medical device therapy. The system can include permissions to determine who, how and when information and/or control is shared that can consider factors such as time, location and relationship with the patient.Type: GrantFiled: January 12, 2022Date of Patent: January 9, 2024Assignee: Tandem Diabetes Care, Inc.Inventors: Manuel Jaime, Josh Juster, Larkin Lowrey, Geoffrey A. Kruse, Garrett Marin, Michael Michaud
-
Publication number: 20230166033Abstract: In an infusion pump system that includes a pump that may have a user interface for pump programming, one or more smartphones or other remote control devices that interface with the infusion pump, and/or an automated insulin delivery algorithm, there is a potential conflict between commands such as boluses being programmed on multiple devices and/or calculated by the AID algorithm at the same time. In order to avoid low glucose levels that could result from delivering multiple boluses from these various sources when only one bolus is needed, systems and methods disclosed herein provide a bolus permissions and prioritization scheme that prioritizes boluses programmed with the infusion pump and one or more remote control devices and calculated by a closed loop delivery algorithm.Type: ApplicationFiled: November 30, 2022Publication date: June 1, 2023Inventors: Dwight Lee, Christoper Jung, Amanda Lennard, Garrett Marin
-
Patent number: 11654236Abstract: Disclosed herein are systems and methods for mitigating the risk of insulin stacking in automated insulin delivery systems. In AID systems configured to both automatically calculate insulin delivery based on glucose levels and receive manual programming of meal boluses configured to counteract carbohydrates in a meal, insulin stacking can result if the system automatically increases insulin delivery based on a rise in glucose levels in response to consumption of a meal and the user later programs a meal bolus for the meal. The risk of such double dosing is mitigated by the systems and methods disclosed herein by enabling the system to account for recent automated insulin increases when a meal bolus is programmed.Type: GrantFiled: November 19, 2020Date of Patent: May 23, 2023Assignee: Tandem Diabetes Care, Inc.Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Scott Leas, Betsy Dokken, Garrett Marin, Nicholas Sherer
-
Publication number: 20220223250Abstract: Disclosed herein are systems and methods for remotely monitoring and/or controlling medical therapy of a patient. Embodiments of the current disclosure provide a remote monitoring and/or control architecture that can establish a predetermined set of permissions for real time monitoring of patient data and/or notifications and/or control of medical device therapy. The system can include permissions to determine who, how and when information and/or control is shared that can consider factors such as time, location and relationship with the patient.Type: ApplicationFiled: January 12, 2022Publication date: July 14, 2022Inventors: Manuel Jaime, Josh Juster, Larkin Lowrey, Geoffrey A. Kruse, Garrett Marin, Michael Michaud
-
Publication number: 20220062553Abstract: Apparatuses and methods for transitioning to sleep mode or otherwise modified glucose target range in automated insulin delivery systems. For example, sleep mode can include a lower glucose target and/or lower and narrower glucose target range because of fewer variables that affect glucose values during sleep such as eating and exercise. Due to increased stability provided by the sleep mode target range, it is desirable to transition to the sleep mode target range as quickly as possible, while ensuring the transition is done safely and does not risk low glucose or hypoglycemia by too quickly switching to the lower and narrower target range. Systems and methods disclosed herein therefore provide various approaches for safely and quickly transitioning to sleep mode or other modified target ranges in order to improve time in range by being more aggressive to get to the lower sleep mode or other target faster without risking hypoglycemia.Type: ApplicationFiled: August 27, 2021Publication date: March 3, 2022Inventors: Alexandra Elena Constantin, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Virginia S. Lu, Garrett Marin
-
Publication number: 20210154405Abstract: Disclosed herein are systems and methods for mitigating the risk of insulin stacking in automated insulin delivery systems. In AID systems configured to both automatically calculate insulin delivery based on glucose levels and receive manual programming of meal boluses configured to counteract carbohydrates in a meal, insulin stacking can result if the system automatically increases insulin delivery based on a rise in glucose levels in response to consumption of a meal and the user later programs a meal bolus for the meal. The risk of such double dosing is mitigated by the systems and methods disclosed herein by enabling the system to account for recent automated insulin increases when a meal bolus is programmed.Type: ApplicationFiled: November 19, 2020Publication date: May 27, 2021Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Scott Leas, Betsy Dokken, Garrett Marin, Nicholas Sherer
-
Publication number: 20210113766Abstract: Disclosed herein are systems and methods incorporating an ambulatory infusion pump and a CGM. These systems that can include software and related methods to provide improved automated insulin delivery algorithms that enable the algorithms to safely continue delivering insulin for some time periods of missing or known inaccurate glucose values.Type: ApplicationFiled: October 20, 2020Publication date: April 22, 2021Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Garrett Marin, Paul Harris, Thomas R. Ulrich, Brendan Nichols
-
Publication number: 20210001044Abstract: Disclosed herein are apparatuses and methods incorporating an infusion pump and a CGM that can include software that automatically populates a blood glucose section of a bolus calculator with a most recent valid CGM value. The software can additionally be programmed to automatically populate the bolus calculator with a single CGM reading only when one or more predefined conditions are met that aid in mitigating the risk of inaccurate and/or invalid single CGM readings.Type: ApplicationFiled: July 6, 2020Publication date: January 7, 2021Inventors: Michael Michaud, Garrett Marin, Geoffrey A. Kruse, Jacob Kearns, Thomas R. Ulrich, Trevor Denbo, David Berger
-
Publication number: 20200368430Abstract: Disclosed herein are apparatuses and methods that account for exercise in closed loop insulin delivery systems. Rather than increasing a target insulin on board (IOB) as glucose levels rise, which would increase insulin delivery to address the raised glucose levels, when a user indicates that the user will be exercising raised glucose levels are addressed by reducing the target IOB within the closed loop algorithm. By reducing the target IOB, the algorithm responds less aggressively to pre-exercise food, and does not build up the IOB that can cause dangerously low glucose levels once the exercise also begins lowering glucose levels.Type: ApplicationFiled: May 20, 2020Publication date: November 26, 2020Inventors: Thomas R. Ulrich, Michael Michaud, Geoffrey A. Kruse, Paul Harris, Garrett Marin